<DOC>
	<DOCNO>NCT00999180</DOCNO>
	<brief_summary>The objective study ass association botulinum toxin type A kinesitherapy superior kinesitherapy 0,9 % saline functional performance post-stroke patient . Hypothesis H ( 0 ) : BT-A associate kinesitherapy superior kinesitherapy function hemiparetic post-stroke patient . H ( 1 ) : BT-A associate kinesitherapy superior kinesitherapy function hemiparetic post-stroke patient .</brief_summary>
	<brief_title>Botulinum Toxin Type A Kinesitherapy Post-stroke Patients</brief_title>
	<detailed_description>The patient orient regard study step potential risk procedure . They assess spasticity-experienced physical therapist . Demographical data collect questionnaire , range movement measure goniometer , muscle tone determine modify Ashworth scale , patient dorsal decubitus . The presence hypertonia equal superior 2 assign respective muscle injection . Then patient conduct another room , another therapist assess functional performance `` time go '' ( TUG ) test , six-minutes duration walking , Fugl-Meyer scale upper limb , patient seat position . During TUG test patient ask stand chair walk 3 meter , turn around 180 degree , walk back chair , assume 10 second normal . The 6 minute walk test measure distance meter previously demarcate place . A staff constantly stimulate patient verbally , walk fast possible . Posteriorly patient set another room , neurologist inject one two possible substance , pre-determined dosage dilution . The botulinum toxin group syringe fill botulinum toxin type A ( Dysport ) control group syringe fill saline . All patient reassess three six month new injection , undergo last evaluation nine month . During period patient follow IBR facility undergo protocol physical therapy comprise muscle strengthen , flexibility , endurance , functional training ( appendix D ) . There appointment twice week , one day apart . The duration session 30 minute , 1 minute interval activity . The first 5 minute comprise flexibility exercise , sustain stretch ( 15 second ) joint mobilization , follow muscle strength exercise involve concentric eccentric movement , progressive charge depend patient performance within follow 10 minute . The last 15 minute functional training involve gait upper limb activity combine endurance training . These activity divide two day : first day trunk upper limb , second pelvic , gait , low limb exercise . This protocol carry two physical therapist blind regard drug injection .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Clinical diagnosis cerebrovascular accident indication botulinum toxin injection ( Hypertonia equal superior 2 accord Ashworth scale ) . Patients follow physical therapy staff IBR HAS , 2 appointment per week . Patients sexes age superior 18 year To minimum one maximum five year post poststroke . Patients age superior 70 year Cognitive impairment Poorly control arterial hypertension Presence joint blockade Unable walk independently Use orthesis gait aid Use botulinum toxin within last six month Use systemic drug reduction tonus Blood , liver , kidney disorder pregnant lactate woman Cardiopathy Comprehension aphasia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Botulinum Toxin</keyword>
	<keyword>Rehabilitation</keyword>
	<keyword>Stroke</keyword>
</DOC>